Perspective Therapeutics (CATX) Earnings Date & Reports

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CATX is expected to report earnings to rise 2.04% to -25 cents per share on August 18

Perspective Therapeutics CATX Stock Earnings Reports

Q2'26

Est.

$-0.26

Q1'26

Beat

by $0.05

Q4'25

Missed

by $0.16

Q3'25

Missed

by $0.03

Q2'25

Est.

$-0.29

The last earnings report on May 11 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 7.66M shares outstanding, the current market capitalization sits at 336.44M.

View a ticker or compare two or three

Compare

CATX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CATX